|
EXP002001
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M
|
siRNA
|
no |
|
|
no |
no |
|
EXP002002
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M1
|
siRNA
|
no |
|
|
no |
no |
|
EXP002003
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M2
|
siRNA
|
no |
|
|
no |
no |
|
EXP002004
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M3
|
siRNA
|
no |
|
|
no |
no |
|
EXP002005
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M4
|
siRNA
|
no |
|
|
no |
no |
|
EXP002006
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M5
|
siRNA
|
no |
|
|
no |
no |
|
EXP002007
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M6
|
siRNA
|
no |
|
|
no |
no |
|
EXP002008
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
v-M8
|
oligonucleotide
|
no |
|
yes |
yes |
yes |
|
EXP002009
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
B-M8
|
oligonucleotide
|
no |
|
yes |
yes |
yes |
|
EXP002010
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
B-MSP-M8
|
oligonucleotide
|
no |
|
yes |
yes |
yes |
|
EXP002011
|
Low Molecular Weight Alginate Oligosaccharides as Alternatives to PEG for Enhan…
|
2024 |
Peptide E
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002012
|
Low Molecular Weight Alginate Oligosaccharides as Alternatives to PEG for Enhan…
|
2024 |
Peptide Y
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002013
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
TAT
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002014
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq1
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002015
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq2
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002016
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq3
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002017
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq4
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002018
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq5
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002019
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq6
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002020
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq7
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002021
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq8
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002022
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq9
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002023
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
seq10
|
siRNA
|
no |
no |
|
no |
no |
|
EXP002024
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-13
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002025
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-13-OX
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002026
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-15
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002027
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-15-OX
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002028
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-17
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002029
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-17-OX
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002030
|
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-…
|
2025 |
Y2-13-OX
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002031
|
A Novel Cell-Penetrating Peptide–VEGF siRNA Complex That Mediates Inhibition of…
|
2025 |
Ara27
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002032
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
LAU-DP7
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002033
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
MYR-DP7
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002034
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
PAL-DP7
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002035
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
STE-DP7
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002036
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
LAU-DP7
|
siRNA
|
no |
|
|
yes |
no |
|
EXP002037
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
MYR-DP7
|
siRNA
|
no |
|
|
yes |
no |
|
EXP002038
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
PAL-DP7
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP002039
|
In silico optimized cell-penetrating peptides achieve transdermal siRNA deliver…
|
2026 |
STE-DP7
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP002040
|
Selective peptide–guided transcytosis enhances extracellular vesicle–mediated s…
|
2026 |
RVG
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002041
|
Selective peptide–guided transcytosis enhances extracellular vesicle–mediated s…
|
2026 |
CPP.16
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002042
|
Selective peptide–guided transcytosis enhances extracellular vesicle–mediated s…
|
2026 |
RVG
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002043
|
Selective peptide–guided transcytosis enhances extracellular vesicle–mediated s…
|
2026 |
CPP.16
|
siRNA
|
no |
|
|
yes |
no |
|
EXP002044
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002045
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211R
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002046
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P5R
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002047
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P2
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002048
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
BP2R
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002049
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211W
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002050
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211RK
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002051
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211RW
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002052
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SRGDK
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002053
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
RREP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002054
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
REPR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002055
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SREPRGD
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002056
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SREPRGDK
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002057
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SREP4R
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002058
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211F1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002059
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211F2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002060
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211F3
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002061
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
P211F4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002062
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SP211
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002063
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
SP211RGD
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002064
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HCRRGD
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002065
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
TDHR
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002066
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
T7DH
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002067
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
A6DH
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002068
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
D4RA6H
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002069
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HEP2R
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002070
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
CHP2R
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002071
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HE25
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002072
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HR25
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002073
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HR25A
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002074
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
CHE25
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002075
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HEHR25
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002076
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HRHE25
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002077
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HE24RW
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002078
|
Systematic design of DMBT1-derived peptides correlating physicochemical propert…
|
2025 |
HE25
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002079
|
Cell-penetrating peptides-modified nanocarrier for efficient, batch and noninva…
|
2025 |
TAT
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002080
|
Cell-penetrating peptides-modified nanocarrier for efficient, batch and noninva…
|
2025 |
TAT
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002081
|
Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblas…
|
2025 |
WRAP5
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002082
|
Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblas…
|
2025 |
Tf-WRAP5
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002083
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R6H4-1
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002084
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R6H4-1
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002085
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R6H4-2
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002086
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R6H4-2
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002087
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R6H4-3
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002088
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R6H4-3
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002089
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R4H6-1
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002090
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R4H6-1
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002091
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R4H6-2
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002092
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R4H6-2
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002093
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R5H5
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002094
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R5H5
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002095
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R6S4
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002096
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R6S4
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002097
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
PEI-R4S6
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002098
|
Arginine-rich hydrophobic polyethylenimine: Potent agent with simple components…
|
2013 |
Hex-PEI-R4S6
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002099
|
Transdermal siRNA delivery by pH-switchable micelles with targeting effect supp…
|
2020 |
SCP
|
siRNA
|
no |
yes |
yes |
no |
no |
|
EXP002100
|
Transdermal siRNA delivery by pH-switchable micelles with targeting effect supp…
|
2020 |
SCP
|
siRNA
|
yes |
yes |
yes |
no |
no |